← The Wire
IMRXNasdaq
Immuneering Corp
Pharmaceutical Preparations · DE · CIK 1790340
Developing novel anti-cancer medicines to keep patients alive and help them thrive
red 8-K · 90d
$271M
Market cap
$5.05
Last close
+6.1%
1D
+13.7%
5D
1.9M
Volume
Price · last 39 sessions-6.2%
May 4L $3.92 · H $5.77Jun 29
93
Total filings
Jun 15, 2026
Last filing
12/31
Fiscal year end
8-KExecutive ChangeJun 15, 20268-KShareholder VoteJun 11, 20268-KCompany UpdateJun 1, 202610-Q10-QMay 15, 20268-KResults of OperationsMay 15, 2026DEFA14ADEFA14AApr 20, 2026DEF 14ADEF 14AApr 20, 202610-K10-KMar 6, 20268-KResults of OperationsMar 6, 20268-KCompany UpdateJan 7, 202610-Q10-QNov 12, 20258-KResults of OperationsNov 12, 2025424B5424B5Sep 25, 20258-KMaterial Agreement · Company UpdateSep 25, 2025424B5424B5Sep 24, 20258-KMaterial Agreement · Equity IssuanceSep 24, 20258-KMaterial Agreement · Equity IssuanceAug 25, 202510-Q10-QAug 13, 20258-KResults of OperationsAug 13, 2025424B5424B5Jun 23, 20258-KCompany UpdateJun 17, 20258-KShareholder VoteJun 16, 202510-Q10-QMay 5, 20258-KResults of OperationsMay 5, 2025DEFA14ADEFA14AApr 21, 2025DEF 14ADEF 14AApr 21, 2025424B5424B5Mar 20, 202510-K10-KMar 20, 20258-KResults of OperationsMar 20, 20258-KCompany UpdateJan 13, 20258-KCompany UpdateJan 7, 202510-Q10-QNov 13, 20248-KResults of OperationsNov 13, 20248-K/AExecutive ChangeOct 2, 20248-KCompany UpdateSep 12, 202410-Q10-QAug 6, 20248-KResults of OperationsAug 6, 20248-KShareholder VoteJun 13, 20248-KExecutive ChangeMay 23, 202410-Q10-QMay 7, 20248-KResults of OperationsMay 7, 2024DEFA14ADEFA14AApr 23, 2024DEF 14ADEF 14AApr 23, 20248-KExecutive Change · Company UpdateMar 14, 202410-K10-KMar 1, 20248-KResults of OperationsMar 1, 20248-KBylaw AmendmentFeb 2, 2024SC 13GSC 13GJan 26, 202410-Q10-QNov 9, 20238-KResults of OperationsNov 9, 202310-Q10-QAug 3, 20238-KResults of OperationsAug 3, 20238-KShareholder VoteJun 15, 20238-KExecutive ChangeJun 14, 202310-Q10-QMay 4, 20238-KCompany UpdateMay 4, 2023DEFA14ADEFA14AMay 1, 2023DEF 14ADEF 14AMay 1, 20238-KMaterial AgreementApr 19, 2023424B5424B5Apr 19, 2023424B5424B5Apr 18, 20238-KResults of Operations · Reg FD DisclosureApr 18, 202310-K10-KMar 6, 20238-KResults of Operations · Reg FD DisclosureMar 6, 202310-Q10-QNov 10, 20228-KResults of OperationsNov 10, 20228-K/AExecutive ChangeSep 19, 202210-Q10-QAug 10, 20228-KResults of OperationsAug 10, 20228-KExecutive ChangeJul 25, 20228-KShareholder VoteJun 24, 202210-Q10-QMay 10, 20228-KResults of OperationsMay 10, 2022DEFA14ADEFA14AMay 2, 2022DEF 14ADEF 14AMay 2, 202210-K10-KMar 10, 20228-KResults of OperationsMar 10, 2022SC 13GSC 13GFeb 10, 2022SC 13GSC 13GFeb 4, 20228-KExecutive ChangeJan 18, 2022
Insider Activity
◆ Cluster Buy · 5 insidersIn the 90 days to Jan 16, 2026: 5 insiders bought $234K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 16, 2026 | Brakewood Harold EugeneChief Business Officer | Buy | 5,250 | $4.76 | $25K |
| Jan 15, 2026 | Schall Thomas J.Director | Buy | 21,645 | $4.67 | $101K |
| Jan 15, 2026 | Hall Brett MatthewCHIEF SCIENTIFIC OFFICER | Buy | 2,298 | $4.57 | $11K |
| Jan 13, 2026 | Neufeld Leah RCHIEF PEOPLE OFFICER | Buy | 2,626 | $4.15 | $11K |
| Jan 12, 2026 | Feinberg PeterDirector | Buy | 20,000 | $4.35 | $87K |
| Oct 3, 2025 | Feinberg PeterDirector | Buy | 7,500 | $6.67 | $50K |
| Oct 1, 2025 | Bookman MichaelCHIEF LEGAL OFFICER, SECRETARY | Buy | 1,020 | $6.83 | $7K |
| Oct 1, 2025 | Neufeld Leah RCHIEF PEOPLE OFFICER | Buy | 800 | $6.38 | $5K |
| Oct 1, 2025 | Morales MalloryChief Accounting Officer | Buy | 300 | $6.39 | $2K |
| Sep 30, 2025 | Feinberg PeterDirector | Buy | 7,500 | $7.03 | $53K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance